Abpro Bio Co., Ltd is a biotechnology company that specializes in the development and commercialization of biopharmaceuticals, focusing on bispecific antibodies for cancer treatment. It uses high-speed technology in its manufacturing processes.

Headquarters
139, Techno Jungang-Daero, Yuga-Myeon, Dalseong-Gun
Daegu; Daegu;

Contact Details: Purchase the Abpro Bio Co., Ltd. report to view the information.

Website: http://www.ugint.co.kr

Basic Information

Total Employees:

Purchase the Abpro Bio Co., Ltd. report to view the information.

Outstanding Shares:

Purchase the Abpro Bio Co., Ltd. report to view the information.

Registered Capital:

Purchase the Abpro Bio Co., Ltd. report to view the information.

Financial Auditors:

Purchase the Abpro Bio Co., Ltd. report to view the information.

Incorporation Date:

August 12, 2004

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Ownership Details

Purchase this report to view the information.

8.3%

Subsidiaries

(주)에이비프로파마

100%

(주)유지글로벌

100%

Abpro Bio International Inc

100%

Company Performance

Financial values in the chart are available after Abpro Bio Co., Ltd. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

123.09%▲

Total operating revenue

N/A

Operating Profit/Loss (EBIT)

-610.74%▼

EBITDA

-699.55%▼

Net Profit/Loss for the Period

-2378.91%▼

Total Assets

-41.73%▼

Total Equity

-49.19%▼

Operating Profit Margin (ROS)

-165.11%▼

Net Profit Margin

-240.97%▼

Return on Equity (ROE)

-74.85%▼

Debt/Equity

16.22%▲

Quick Ratio

-0.32%▼

Cash Ratio

0.2%▲

Abpro Bio Co., Ltd. (South Korea)